Journal Information
Vol. 99. Issue 2.
Pages 89-90 (March 2008)
Vol. 99. Issue 2.
Pages 89-90 (March 2008)
Opinion article
Full text access
Present and Future of Biologic Therapy in Dermatology
Visits
7054
J.L. Sánchez-Carazo
Corresponding author
sanchez-joscar@gva.es
Correspondence: Servicio de Dermatología, Consorcio Hospital General Universitario, Avda. Tres Cruces s/n, 46014 Valencia, Spain.
Correspondence: Servicio de Dermatología, Consorcio Hospital General Universitario, Avda. Tres Cruces s/n, 46014 Valencia, Spain.
Servicio de Dermatología, Hospital General Universitario de Valencia, Valencia, Spain
This item has received
Article information
Full text is only aviable in PDF
Recommended Reading
[Gottlieb, 2004]
A. Gottlieb.
Expanding the use of biologic therapies in dermatology. In: Selective T-cell targeting with biologics in dermatology: increasing clinical evidence [symposium].
Presented at: 10th International Psoriasis Symposium™ 2004, pp. 10-13
[Gottlieb and Bos, 2004]
A.B. Gottlieb, J.D. Bos.
Recombinantly Engineered human proteins: transforming the treatment of psoriasis.
Clin Inmunol, 105 (2002), pp. 105-116
[Papp, 2004]
K.A. Papp.
Biologics—exploring new frontiers in the treatment of psoriasis: hot off the press—a biologic update [symposium].
Presented at: 10th International Psoriasis Symposium™ 2004, pp. 10-13
[Smith et al., 2007]
D.I. Smith, P.M. Swamy, M.P. Heffernan.
Off-label uses of biologics in dermatology: interferon and intravenous immunoglobulin (part 1 of 2).
J Am Acad Dermatol, 56 (2007), pp. e1-e54
Copyright © 2008. Academia Española de Dermatología y Venereología and Elsevier España, S.L.